The WHO issues its first official guidance on GLP-1 drugs for obesity treatment, as the disease affects over one billion ...

WHO issues conditional guidance on GLP‑1 therapies for obesity, calling for wider access amid high prices, safety questions & ...

WHO issues 1st guideline on GLP-1s recommending long-term use with behavioral therapy and notes pricing changes from major manufacturers.

New guidelines from the World Health Organization (WHO) recommend using GLP-1 medications to help manage obesity along with a ...

To address the growing global health challenge of obesity, which affects more than 1 billion people, the World Health ...

On World AIDS Day, the World Health Organization (WHO) calls on governments and partners to rapidly expand access to new ...

The World Health Organization (WHO) has made a significant recommendation regarding the use of weight loss drugs like Wegovy ...

The United States is not commemorating World AIDS Day this year as it has done for decades in the past. The commemoration has ...

The World Health Organization (WHO) on Monday issued its first-ever global guidelines on the use of GLP-1 medications for treating obesity as a chronic illness. In a press release, the WHO said ...

The World Health Organization issued new guidelines recommending the use of GLP-1 drugs for adults with obesity and called for action on manufacturing and affordability.

A range of blockbuster weight-loss and diabetes drugs could help shift the trajectory of the global obesity epidemic, which ...

The World Health Organization on Monday issued its first guideline on the use of GLP-1 therapies for obesity, conditionally ...